Latest news
Loading news…
Pathos
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chicago, Illinois, United States Founded 2020 11-50 employees For Profit
Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.
Pathos on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$446.99M
Funding Rounds
3
Last Funding
Acquisitions
2
Monthly Visits
Contacts
64
Patents
0
5 trademarks
About Pathos
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 4
- Patents granted
- 0
- Trademarks
- 5
- IT spend
- $1.13M
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- Sub-organizations
- 1
- News articles
- 20
- HQ
- Chicago, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -2.6
- Trend (90d)
- -0.3
- Last leadership hire
- May 8, 2025
Pathos Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
Pathos Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| DeuterOncology | — | 2026-05-06 | Pathos | BiotechnologyMedicalOncology | Belgium |
| Rain Oncology | — | 2023-12-13 | Pathos | BiopharmaBiotechnologyClinical TrialsHealth CareOncologyPharmaceuticalTherapeutics | United States |
1–2 of 2Show
Page 1 / 1
64
professional contacts at Pathos
Contact execs at Pathos →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Pathos
Loading news…
FAQs about Pathos
People who checked this page also checked these
Browse the full Acquirezy directory.